Monte Rosa Therapeutics
GLUE
#6710
Rank
$0.47 B
Marketcap
$7.79
Share price
-8.14%
Change (1 day)
128.45%
Change (1 year)

Monte Rosa Therapeutics (GLUE) Fails to deliver data

Key failure to deliver metrics for Monte Rosa Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Monte Rosa Therapeutics (GLUE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Monte Rosa Therapeutics (GLUE) - since 2021

Volume in USD (price x number of shares), data since 2021

Monte Rosa Therapeutics (GLUE) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024$3.82 M51.81%
2023$2.52 M-88.7%
2022$22.31 M145.9%
2021$9.07 M